| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |